159489-34-6

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 60076-43-9 Toluene-4-sulfonic acid (2R,3R,4R,5R,6S)-2-azidomethyl-5-benzyloxycarbonylamino-3-hydroxy-6-methoxy-tetrahydro-pyran-4-yl ester 

Downstream Products

• 159489-35-7 [(2S,3R,4R,6S)-6-(tert-Butoxycarbonylamino-methyl)-4-hydroxy-2-methoxy-tetrahydro-pyran-3-yl]-carbamic acid benzyl ester 
• 159489-41-5 {(S)-1-[(2S,3R,4R,6S)-6-(tert-Butoxycarbonylamino-methyl)-4-hydroxy-2-methoxy-tetrahydro-pyran-3-ylcarbamoyl]-2-methyl-propyl}-carbamic acid benzyl ester 
• 159489-43-7 {(S)-1-[(2S,3R,4R,6S)-6-(Benzyloxycarbonylamino-methyl)-4-hydroxy-2-methoxy-tetrahydro-pyran-3-ylcarbamoyl]-2-methyl-propyl}-carbamic acid benzyl ester 
• 159489-45-9 {(S)-1-[(2S,3R,4R,6S)-4-Benzyloxy-6-(benzyloxycarbonylamino-methyl)-2-methoxy-tetrahydro-pyran-3-ylcarbamoyl]-2-methyl-propyl}-carbamic acid benzyl ester 
• 159489-48-2 {(S)-1-[(3R,4R,6S)-4-Benzyloxy-6-(benzyloxycarbonylamino-methyl)-2-oxo-tetrahydro-pyran-3-ylcarbamoyl]-2-methyl-propyl}-carbamic acid benzyl ester 

Relevant academic research and scientific papers

The revised structure of the antibiotic Tue 1718 B confirmed by synthesis

The revised structure of the dipeptide antibiotic Tue 1718 B was confirmed by synthesis of two possible diastereoisomers of L-valyl-dihydroxylysine 2. Comparison of the NMR spectra of the synthetic and natural products indicates (2S,3S,5S)- or (2S,3R,5S)-